Understanding gene-environment interactions leads to possible preventive treatment
An inhaled form of a high blood pressure medication has potential to treat certain types of anxiety as well as pain, according to a new study by the Centre for Addiction and Mental Health (CAMH).
Anxiety disorders are usually treated with different types of medications, such as antidepressants, and psychotherapy. Amiloride is a medication offering a new approach, as a short-acting nasal spray that could be used to prevent an anxiety attack.
“Inhaled amiloride may prove to have benefits for panic disorder, which is typically characterized by spells of shortness of breath and fear, when people feel anxiety levels rising,” says lead author Dr. Marco Battaglia, Associate Chief of Child and Youth Psychiatry and Clinician Scientist in the Campbell Family Mental Health Research Institute at CAMH.
The study was based on understanding the key physiological changes in brain functioning that are linked to anxiety and pain sensitivity. The researchers then tested a molecule, amiloride, which targets this functioning.
Amiloride was inhaled so that it could immediately access the brain. The study showed that it reduced the physical respiratory signs of anxiety and pain in a preclinical model of illness. This therapeutic effect didn’t occur when amiloride was administered in the body, as it didn’t cross the blood-brain barrier and did not reach the brain.
Results were published in the Journal of Psychopharmacology.
The role of early life adversity
The study is based on years of research into how a person’s early life experiences affect their genes, says Dr. Battaglia. Childhood adversity, such as loss or separation from parents, increases the risk of anxiety disorders and pain, among other health issues.
At a molecular level, these negative life experiences are linked to changes in some genes of the ASIC (acid-sensing-ion-channels) family. While the DNA itself doesn’t change, the way it functions is affected.
DNA is converted into working proteins through a process called gene expression. As a result of childhood adversity, some ASIC genes showed increased expression and epigenomic changes. (“Epigenomic” refers to changes in gene regulation that can inherited by children). Overlapping genetic changes were also seen in blood taken from twins who responded to specific tests designed to provoke panic.
These genetic changes are linked to physical symptoms. Breathing can be affected, due to over-sensitivity to higher carbon dioxide levels in the air. In such situations, a person might hyperventilate and experience growing anxiety. Preclinical and human data are strikingly similar in this regard. “As a treatment, amiloride turned out to be very effective preclinically,” says Dr. Battaglia.
The next step in his research is to test whether it eases anxiety symptoms. Dr. Battaglia is now launching a pilot clinical trial, supported through a seed grant from CAMH’s new Discovery Fund. Collaborators at the University of Utah are testing the drug’s safety.
Amiloride has been used as an oral treatment for decades for hypertension, and as an inhaled spray in a few experimental studies of cystic fibrosis, he notes. The researchers are therefore further ahead than if they had to develop and test an entirely new medication.
The Latest on: Amiloride
via Google News
The Latest on: Amiloride
- Digoxin Use in Modern Medicineon March 18, 2020 at 5:00 pm
CHF is a myocardial dysfunction caused by the contractile performance of the heart, ventricular relaxation/filling of the heart, or both. In CHF, contractility is decreased, which in turn reduces ...
- Monogenic Forms of Low-Renin Hypertensionon March 17, 2020 at 5:00 pm
b Due to production of non-aldosterone mineralocorticoids. c Acquired forms due to DOC-producing tumors. d Due to increased activity of MCRs. e Acquired forms due to either licorice ingestion or ...
- Dr. Shahbaz A. Malikon March 17, 2020 at 5:00 pm
Dr. Shahbaz A. Malik is a hematologist in Austin, Texas and is affiliated with St. David's South Austin Medical Center. He received his medical degree from Virginia Commonwealth University School ...
- Dr. Richard L. Lubmanon March 16, 2020 at 5:00 pm
Dr. Richard L. Lubman is a pulmonologist in Los Angeles, California and is affiliated with multiple hospitals in the area, including Keck Medical Center of USC and USC Norris Comprehensive Cancer ...
- Sodium Citrate and Citric Acidon March 2, 2020 at 4:00 pm
If you are on a low-salt or salt-free diet. If you are taking any of these drugs: Amiloride, eplerenone, spironolactone, or triamterene. If you are taking or have recently taken any of these drugs: ...
- Amiloride and Hydrochlorothiazideon March 2, 2020 at 4:00 pm
This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider.
- Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channelon February 21, 2020 at 11:01 am
After blocking the epithelial sodium channel ENaC with amiloride (10 μM), cells were stimulated with chlorophenylthio–adenosine 3′,5′-cyclic monophosphate (CPT-cAMP) (100 μM) plus VX-770 (1 μM) to ...
- Men and women with stage III chronic kidney disease needed for medication studyon February 26, 2019 at 11:28 am
We are looking for men and women, ages 19-65, with Stage III CKD, non-diabetic or who have controlled diabetes, and who are not currently taking spironolactone or amiloride. The study lasts 16 weeks, ...
- Treatment of Feline Myocardial Diseaseson April 24, 2018 at 10:05 pm
Potassium-Sparing Diuretics (e.g., Spironolactone, Amiloride) Spironolactone (2–4 mg/kg PO BID) or amiloride can be administered to patients with recurrent congestive signs receiving maximal loop and ...
- What Conditions does Amiloride HCL Treat?on May 22, 2017 at 12:22 pm
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except ...
via Bing News